A Chinese company called Xteink has unveiled a new compact e-reader that sticks to the back of an iPhone. Named Xteink X4, the portable e-book reader sports a 4.3-inch e-ink screen and magnetically ...

We may earn a commission from links on this page. Deal pricing and availability subject to change after time of publication.

You can always tell when a tech company pays attention to what people want. The Insta360 X4 Air is that rare camera that feels like it was built by listening first, engineering second. After years of ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

On its face, the Insta360 X4 Air doesn't appear to be much of a departure from Insta360's flagship X5 camera, or indeed its older X4 camera. However, there are major changes to be found under the hood ...

Just six months after launching the excellent X5, Shenzhen-headquartered Insta360 is back with another 360 camera: the X4 Air. If you’re wondering how the line’s numbering is going backwards, it’s ...

The X4 Air is also getting a larger sensor and the X5’s user-replaceable lenses. The X4 Air is also getting a larger sensor and the X5’s user-replaceable lenses. is a senior reporter who’s been ...

Insta360 has launched a new camera that sits between the X4 and its current flagship, the X5. The company says the new Insta360 X4 Air is lightest-ever 8K 360-degree camera at just 165 grams. It is ...

BMW’s performance SUV coupe is back with a fresh lease offer, giving drivers a chance to grab serious speed with everyday usability. The BMW X4 M has carved out a unique spot in BMW’s lineup, blending ...

Abstract: This project presents the design and development of a miniature robot car enhanced with autonomous navigation and real-time mapping capabilities. The system utilizes an ESP32 microcontroller ...

X4 Pharmaceuticals is again shrinking its workforce, this time by 50% as the company pushes to save costs and finish a phase 3 study of its Xolremdi (mavorixafor) in neutropenia. The layoffs are ...